Neuronetics, Inc. 8-K
Research Summary
AI-generated summary
Neuronetics, Inc. Reports Annual Meeting: Directors Elected, Equity Plan Approved
What Happened
- Neuronetics, Inc. announced the results of its Annual Meeting of Stockholders held May 28, 2026 (reported in an 8-K filed May 29, 2026). A total of 55,950,118 shares (≈80.41% of outstanding eligible shares) were present in person or by proxy, constituting a quorum.
- All nominees for director were elected to one-year terms (through the 2027 Annual Meeting). The company’s appointment of KPMG LLP as independent registered public accounting firm for fiscal 2026 was ratified. Stockholders also approved, on a non-binding advisory basis, executive compensation (say-on-pay) and approved the Neuronetics, Inc. 2026 Equity Incentive Plan.
Key Details
- Director election vote totals (For / Withheld; 14,661,594 broker non-votes were present):
- Avinash N. Amin, M.D.: 33,982,534 For / 7,305,990 Withheld
- Robert A. Cascella: 29,304,597 For / 11,983,927 Withheld
- Sheryl L. Conley: 29,304,311 For / 11,984,213 Withheld
- Sasha S. Cucuz: 28,512,554 For / 12,775,970 Withheld
- Glenn P. Muir: 29,281,048 For / 12,007,476 Withheld
- Daniel L. Reuvers: 34,472,656 For / 6,815,868 Withheld
- Megan R. Rosengarten: 28,794,454 For / 12,494,070 Withheld
- Auditor ratification (Proposal 2): KPMG LLP ratified — 47,194,967 For / 6,924,816 Against / 1,830,335 Abstain.
- Say-on-pay advisory (Proposal 3): 29,133,360 For / 11,503,294 Against / 651,870 Abstain; 14,661,594 broker non-votes.
- 2026 Equity Incentive Plan approval (Proposal 4): 23,802,955 For / 16,651,661 Against / 833,908 Abstain; 14,661,594 broker non-votes.
Why It Matters
- Board continuity confirmed: all nominees were elected for one-year terms, which matters for governance and strategic oversight.
- Auditor ratification keeps KPMG LLP as the company’s independent auditor for fiscal 2026.
- Approval of the 2026 Equity Incentive Plan legally enables the company to grant stock-based compensation to employees and directors; this can affect future share dilution and executive incentives.
- The non-binding say-on-pay passed, showing shareholder support for executive compensation, though the level of dissent (over 11.5M votes against) is a record of investor sentiment the company may consider.
Loading document...